As gene mapping nears $1,000, will it improve our health?

crossing over

The cost of mapping a person’s full genetic profile has been dropping quickly. Now, doctors are struggling with a new question: how to use the information to improve people’s health. Genetic profiling, known as genome sequencing, already is helping researchers diagnose rare or mysterious illnesses. Other specialists use the process to tailor drug therapies for advanced cancer patients. The latest research focuses on how to use genome sequencing in basically healthy people, especially those who may have a family history of disease but no symptoms.

View the original article here: Making gene mapping part of everyday care

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
ChatGPT-Image-May-13-2026-11_56_08-AM
After slashing global health aid by $19 Billion, Trump moves to tap $2.1 billion moreโ€”to cover shutdown costs
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Foodโ€”health harming industries or life-saving innovators?
Screenshot-2026-02-20-at-10.48.04-AM
Deepfakes raise profound ethical questions in science
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.โ€™s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels donโ€™t tell the whole story.
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challengingย 
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.